美国膳食脂肪酸摄入与青光眼的关联
基于美国NHANES 2005-2008数据库中3865名40岁及以上参与者的横断面研究,分析每日膳食多不饱和脂肪酸(PUFA)摄入与青光眼患病率的关联。结果显示,每日膳食二十碳五烯酸(OR 0.06;95%CI 0.00-0.73)和二十二碳六烯酸(OR 0.06;95%CI 0.01-0.87)摄入水平升高与青光眼患病风险降低显著相关;而每日总PUFA摄入量处于第二(OR 2.84;95%CI 1.39-5.79)和第三(OR 2.97;95%CI 1.08-8.15)四分位者,符合青光眼诊断标准的风险显著升高。
要点
- 每日膳食二十碳五烯酸和二十二碳六烯酸摄入水平升高与青光眼患病风险降低显著相关。
- 每日总PUFA摄入量处于第二和第三四分位者,青光眼患病风险显著升高。
- 作者假设在控制总PUFA摄入的同时增加膳食ω-3摄入比例可能对青光眼有保护作用,但需纵向研究或随机临床试验验证。
核心结论
- 每日膳食二十碳五烯酸和二十二碳六烯酸摄入水平升高与青光眼性视神经病变可能性降低相关。
- 每日总PUFA摄入量处于较高四分位者与青光眼风险升高相关,可能源于ω-6与ω-3脂肪酸的相对摄入及其他混杂合并症。
- 作者假设在控制每日总PUFA摄入的同时增加膳食ω-3摄入比例可能对青光眼有保护作用,但需纵向研究或随机临床试验评估这些假设。
研究设计与样本
- 研究类型为横断面研究,数据来自美国国家健康与营养调查(NHANES)2005-2008数据库。
- 纳入3865名40岁及以上、完成视力健康与膳食摄入问卷、并有实验室检查和眼科检查(包括倍频技术视野缺损检测和视盘照片)结果的参与者。
- NHANES于2005至2006年进行数据收集;本研究数据于2017年5月1日至30日从数据库下载,数据分析于2017年6月1日至10月1日进行。
- 加权调查参与者共83 643 392人,其中女性43 660 327人(52.2%),符合青光眼标准者3 076 410人(3.7%)。
主要发现
- 与无青光眼参与者相比,青光眼参与者年龄更大(平均[SE]年龄61.4[0.8]岁 vs 53.7[0.4]岁;P < .001)。
- 每日膳食二十碳五烯酸摄入水平升高与青光眼患病风险降低显著相关(OR 0.06;95%CI 0.00-0.73)。
- 每日膳食二十二碳六烯酸摄入水平升高与青光眼患病风险降低显著相关(OR 0.06;95%CI 0.01-0.87)。
- 每日总PUFA摄入量处于第二四分位者符合青光眼诊断标准的风险显著升高(OR 2.84;95%CI 1.39-5.79)。
- 每日总PUFA摄入量处于第三四分位者符合青光眼诊断标准的风险显著升高(OR 2.97;95%CI 1.08-8.15)。
关键数值与推荐
- 青光眼诊断采用鹿特丹标准,即结合视杯或视杯不对称与视野缺损结果。
- 每日膳食二十碳五烯酸摄入水平升高与青光眼患病风险降低显著相关(OR 0.06;95%CI 0.00-0.73)。
- 每日膳食二十二碳六烯酸摄入水平升高与青光眼患病风险降低显著相关(OR 0.06;95%CI 0.01-0.87)。
- 每日总PUFA摄入量第二四分位者青光眼风险显著升高(OR 2.84;95%CI 1.39-5.79)。
- 每日总PUFA摄入量第三四分位者青光眼风险显著升高(OR 2.97;95%CI 1.08-8.15)。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文指出总PUFA较高四分位与青光眼风险升高的关联可能源于ω-6与ω-3脂肪酸的相对摄入及其他混杂合并症。
- 原文指出需要纵向研究或随机临床试验来评估这些假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Identifying whether an association exists between daily dietary polyunsaturated fatty acid (PUFA) consumption and the prevalence of glaucoma in the United States may provide modifiable dietary risk factors for the development of glaucoma. OBJECTIVE: To analyze the association between glaucoma and daily dietary intake of PUFAs, including ω-3 fatty acids, in the US population. DESIGN, SETTING, AND PARTICIPANTS: Data from 3865 participants in the National Health and Nutrition Examination Survey (NHANES) 2005-2008 database who were 40 years or older, had participated in the vision health and dietary intake questionnaires, and had available results from laboratory tests and eye examinations that included frequency-doubling technology visual field loss detection tests and optic disc photographs were included. Data collection was performed by NHANES from 2005 to 2006. Data for the present study were downloaded from their database May 1 to 30, 2017. Data analyses were performed from June 1 to October 1, 2017. EXPOSURES: Daily dietary intake of PUFAs, including ω-3 fatty acids. MAIN OUTCOMES AND MEASURES: Prevalence of glaucoma in the United States as defined using the Rotterdam criteria, which included a combination of optic cupping or asymmetry and visual field defect results. RESULTS: Of the 83 643 392 weighted survey participants included in this cross-sectional study, 43 660 327 (52.2%) were women and 3 076 410 (3.7%) met our criteria for having glaucoma. Compared with participants without glaucoma, those with glaucoma were older (mean [SE] age, 61.4 [0.8] vs 53.7 [0.4] years; P < .001). Increased levels of daily dietary intake of eicosapentaenoic acid (odds ratio [OR], 0.06; 95% CI, 0.00-0.73) and docosahexaenoic acid (OR, 0.06; 95% CI, 0.01-0.87) were associated with significantly lower odds of having glaucoma. However, participants with daily total dietary PUFA intake levels in the second (OR, 2.84; 95% CI, 1.39-5.79) and third (OR, 2.97; 95% CI, 1.08-8.15) quartiles showed significantly increased odds of meeting our criteria for a diagnosis of glaucoma. CONCLUSIONS AND RELEVANCE: Increased daily dietary consumption levels of eicosapentaenoic acid and docosahexaenoic acid were associated with lower likelihood of glaucomatous optic neuropathy. However, consumption levels of total PUFAs in the higher quartiles were associated with a higher risk of glaucoma, which may have resulted from the relative intakes of ω-6 and ω-3 fatty acids and other confounding comorbidities. This study also hypothesizes that increasing the proportion of dietary ω-3 consumption levels while controlling overall daily PUFA intake may be protective against glaucoma. However, longitudinal studies or randomized clinical trials are needed to assess these hypotheses.
引用
- Wang YE, Tseng VL, Yu F, et al. Association of Dietary Fatty Acid Intake With Glaucoma in the United States. JAMA Ophthalmol. 2018. PMID: 29270632. doi:10.1001/jamaophthalmol.2017.5702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。